Search results for "vaccines"
Article
Discussing the Origins of the mRNA Therapeutics Field
Andy Geall, co-founder and chief development officer at Replicate Bioscience, discusses the historical context and buildup of the mRNA therapeutics field.
Watch video
Article
Top Process Development Trends for 2022 and a Look into 2023
In parallel, brought on by the obvious commercial success of the warp speed program for COVID-19 vaccines, came a need for reduced timelines, which accelerated the ongoing Industry 4:0 analytics, digi…
Article
Reducing the Risk of RNAse Contamination in mRNA Production
As drug and vaccine manufacturers work to optimize mRNA production processes, one hurdle to overcome is mRNA’s susceptibility to breakdown by ribonuclease (RNase) enzymes introduced during p…
Article
Report from the 12th Plasma Product Biotechnology Forum
Even after the availability of new vaccines and relaxed restrictions, the plasma donations did not return to pre-pandemic levels. Hence, FDA revised recommendations for certain donor deferrals based o…
Article
PEPTalk Event
Visit us at the PepTalk conference in San Diego. Attend our talk, powerpoint presentations, and panel discussions to learn the latest in protein science.
LEARN MORE >> …
Article
Advancing Global Collaboration for Drug Testing, Regulation, and Manufacturing
…laboration to speed biomedical research efforts and to ensure broad access to quality medicines and vaccines.
Read More >>
Article
Increasing mRNA capabilities and capacity for growing market needs
The rapid development of innovative vaccines allowed for the pharmaceutical industry to deliver its first tools in the fight against the COVID-19 pandemic.
READ FULL ARTICLE >>
Article
Register now: Viral Vector Production for Gene Therapy
In partnership with NIBRT, our eLearning course, “Viral Vector Production for Gene Therapy”, is available on the award winning NIBRT Online Academy.
READ MORE >>
Article
Navigating Molecular Diversity
Are you working with biomolecules beyond mAbs?
Read more here >>
Article
Cytiva to provide Arranta Bio 'idea to injection' solutions for integrated manufacturing of mRNA products
Cytiva will provide its FlexFactory single-use manufacturing platform to Arranta Bio ("Arranta"), a leading contract development and manufacturing organization (CDMO) for use in manufacturing mRNAv…